Medical Packaging results, Q3 2024
Net profit, assets, equity and cash flow for Q3 2024, against the same period a year earlier, from the published financial statements.
Net profit12.26 millionEGP · +27.8% vs the same period a year earlier
Total assets227 millionEGP · +20.5% vs the same period a year earlier
Shareholders' equity194 millionEGP · +27.1% vs the same period a year earlier
Operating cash flow15.12 millionEGP · +521.3% vs the same period a year earlier
In short
- Medical Packaging's net profit for Q3 2024 was about 12.26 million EGP, up +27.8% from 9.6 million EGP in Q3 2023.
- Total assets at the end of Q3 2024 were about 227 million EGP, and shareholders' equity about 194 million EGP.
- Operating cash flow for Q3 2024 was positive at 15.12 million EGP.
Key lines against the same period a year earlier
This periodQ3 2023Change
Net profit12.26 million9.6 million+27.8%
Gross profit15.49 million16.13 million−3.9%
Total assets227 million188 million+20.5%
Total liabilities32.89 million35.66 million−7.8%
Shareholders' equity194 million153 million+27.1%
Total liabilities and equity227 million188 million+20.5%
Operating cash flow15.12 million-3.59 million+521.3%
Investing cash flow-1.13 million-3.86 thousand−29191.5%
Financing cash flow30.71 million13.87 million+121.4%
Net change in cash44.71 million10.28 million+334.9%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Medical Packaging's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy